Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Myeloid 1 Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 351 pembrolizumab 327 Pemetrexed 249 Cisplatin 221 Paclitaxel 149 Nivolumab 139 durvalumab 134 Docetaxel 112 osimertinib 111 atezolizumab 107 Specimen Handling 91 Radiotherapy 89 Drug Therapy 87 Magnetic Resonance Spectroscopy 78 Etoposide 78 Radiosurgery 74 Gemcitabine 72 Ipilimumab 55 130-nm albumin-bound paclitaxel 54 Bevacizumab 53 cemiplimab 47 tislelizumab 46 Blood Specimen Collection 43 Cetuximab 35 Taxes 34 Injections 33 Biopsy 33 Standard of Care 32 Platinum 32 Immunoglobulin G 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

N(4)-oleylcytosine arabinoside × Thoracic × 1 year × Clear all

NCT05498428 2026-05-08

PALOMA-2

Janssen Research & Development, LLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡